From a risk standpoint, Abbott Laboratories (NYSE:ABT) has credit ratings of A+ from Standard & Poor's whereas Mead Johnson Nutrition CO (NYSE:MJN) is several notches lower at BBB minus. Mead Johnson has a forward price-to-earnings ratio of 24x. Medical Devices Medical devices comprise about one-quarter of total sales. The majority of sales come from stents and again the company is the clear global leader. Also supporting this division are solid growth opportunities in blood glucose meters along with cataract and LASIK medical equipment. The comparable in this division is Medtronic, Inc. (NYSE: MDT ) who is the number two player in stents and a well-established medical device maker. Growth rates for stents and pace makers have stalled in recent years amid several industry recalls and a notable slowdown in Europe.